导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 18.50% | 626/969 |
| 近一周 | -2.94% | 650/1048 |
| 近一月 | -0.87% | 225/1046 |
| 近一季 | -1.94% | 534/1033 |
| 近半年 | 28.52% | 294/1007 |
| 近一年 | 17.63% | 620/965 |
| 近两年 | 11.18% | 693/880 |
| 近三年 | -21.46% | 726/782 |
| 成立以来 | 86.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-2.69% 938/1014 |
-2.47% 866/1038 |
37.77% 233/1050 |
- - |
| 2024 | -8.02% 747/1011 |
0.09% 305/960 |
-3.32% 533/983 |
8.54% 748/991 |
-12.43% 965/1011 |
| 2023 | -24.19% 763/952 |
-3.88% 767/880 |
-4.11% 459/895 |
-15.80% 791/915 |
-2.32% 256/952 |
| 2022 | -32.31% 668/867 |
-14.53% 233/773 |
15.64% 109/806 |
-23.55% 791/845 |
-10.41% 793/867 |
| 2021 | 54.56% 9/740 |
-8.19% 454/580 |
42.56% 6/659 |
24.48% 6/704 |
-5.13% 593/740 |
| 2020 | 96.62% 40/554 |
-1.40% 196/419 |
22.59% 237/466 |
8.07% 300/517 |
50.53% 3/554 |
| 2019 | 21.50% 328/410 |
13.65% 1019/1146 |
-12.02% 1142/1228 |
4.89% 200/390 |
15.84% 38/410 |
| 2018 | - - |
- - |
- - |
-0.74% 203/1000 |
-7.52% 127/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 创金合信新能源汽车股票A VS. () |